The preparation is considered relevant for the maintenance of tissue health and the support of epithelial function. Аекол is commonly used to help with tissue management in situations involving certain distressing symptoms related to physical discomfort, such as open injuries, surgical sites, and post-traumatic lesions.

The primary focus of this preparation is on supporting symptoms related to inflammatory or irritative states. It assists with the structural integrity of epithelial tissues, including the skin, mucous membranes, and the cornea. This preparation is thus relevant for managing symptoms associated with compromised tissue integrity, pyo-necrotic complications, and dystrophic diseases of the cornea.

“The combination supports general well-being during symptomatic phases when tissues are subjected to significant oxidative stress.”

Quick Fact: Support for Tissue Recovery

Regulatory References

1. National Center for Biotechnology Information (NCBI)

The drug product Аекол (Aecol) does not currently possess an established, publicly accessible eligibility profile in the formal regulatory documentation of major international government health agencies. This includes bodies such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), Health Canada, and the Australian Therapeutic Goods Administration (TGA).

Because official, government-approved prescribing information or a Summary of Product Characteristics (SmPC) for Aecol is not available in these standardized databases, the following eligibility criteria cannot be officially stated or verified according to the required regulatory standards:

• Populations for whom use is Contraindicated: No populations are formally listed as contraindicated in the official labeling.
• Age-related Eligibility Rules: There are no documented official rules regarding use in pediatric or geriatric age groups.
• Comorbidity-dependent Eligibility Limitations: No restrictions related to conditions like severe renal impairment or hepatic dysfunction are formally established in major regulatory documentation.

In the absence of a verified, government-issued label, a complete eligibility map—which defines populations that are allowed, restricted, or prohibited from using the medicine—cannot be constructed from the mandated authoritative sources.

Interactions with other medicines and products

Aekol is a combination product whose primary components are Vitamin A (Retinol), Vitamin E (Alpha-Tocopherol), and Menadione (Vitamin K3). These vitamins can interact with certain medications and other substances, which may alter their effects or the effects of the co-administered products. Due to the presence of Vitamin K, consult a healthcare professional before use if you are taking blood-thinning medications.

Significant Drug Interactions

It is essential to provide your healthcare provider with a complete list of all prescription, over-the-counter medications, and supplements you are taking. This enables them to manage potential interactions, adjust dosages, or recommend alternative treatments to ensure both your safety and the effectiveness of your therapy.

The pharmacological action of Аекол is defined by the coordinated mechanisms of its three lipophilic components. Alpha-Tocopherol and Beta Carotene function as chain-breaking antioxidants and singlet oxygen quenchers, neutralizing highly reactive molecular species within cell membranes to arrest the lipid peroxidation cascade. The physiological consequence is the stabilization of cell membrane integrity against oxidative stress, which contributes to maintaining the structural stability of tissue components. The Beta Carotene component is also converted to Retinoic Acid, which binds to nuclear receptors (RARs/RXRRs) to modulate gene transcription governing cellular differentiation and maturation, supporting the biological regulation of epithelial cell function. Separately, Menadione acts as a necessary cofactor for the enzyme GGCX (gamma-Carboxylase), facilitating the post-translational gamma-carboxylation of Vitamin K-dependent proteins ( VKDPs), a step essential for activating proteins involved in soft tissue structure.

Аекол (Aekol) is a combination preparation primarily containing Retinol (Vitamin A), α-Tocopherol Acetate (Vitamin E), and Menadione (Vitamin K3), typically in an oily solution, which acts as a polyvitamin and antioxidant agent. The oil is often used topically for its regenerative properties in dermatological and wound care contexts, as well as orally for systemic support.

Administration Routes and Dosage

Because Aekol is available as an oily solution, its method of administration varies significantly based on the condition being treated and the healthcare provider's recommendation.

Important Considerations

• Duration of Use: The full course of treatment, whether topical or oral, is determined individually by a healthcare provider based on the patient's condition and therapeutic response. Do not exceed the prescribed duration.
• Storage: Store the product according to the instructions provided on the packaging, generally in a dark, cool place to preserve the potency of the fat-soluble vitamins.
• Professional Oversight: Due to the inclusion of potent fat-soluble vitamins (A, E, K3) and the diverse clinical applications, Аекол should only be used under the supervision and direct instruction of a qualified healthcare professional. Self-medication with this product is not advised.

Аекол: Recent Clinical Evidence

Clinical research on Аекол, a complex containing Vitamin A (Retinol), Vitamin E (Tocopherol), and Menadione (Vitamin K3), primarily focuses on its profile as a combination vitamin preparation, particularly in areas related to skin healing and anti-inflammatory support.

Historically, the individual components of Аекол—especially Vitamins A and E—have been extensively studied for their roles in epithelial integrity and antioxidant properties, respectively. Recent research efforts, though limited for the specific combination known as Аекол, have centered on its supportive role in conditions involving tissue damage and chronic inflammation.

Clinical and Supportive Research Focus

Studies examining the use of this vitamin combination often focus on the following:

• Tissue Healing: Investigations have evaluated the potential for topical preparations containing these vitamins to support the recovery of damaged skin or mucous membranes. This is largely based on the established role of Vitamin A in epithelial cell differentiation and Vitamin E in wound healing.
• Antioxidant Activity: Research explores the combined ability of Vitamin E and A to neutralize oxidative stress, a factor implicated in various inflammatory conditions. The combination aims to utilize the distinct antioxidant pathways of each component.
• Inflammatory Conditions: Limited, small-scale studies have explored the supportive use of Аекол in certain dermatological conditions or post-procedural recovery where minimizing inflammation is key.

It is important to note that the majority of rigorous, large-scale, placebo-controlled trials often focus on the single active components rather than the specific Аекол formulation. Findings remain largely supportive and observational, underscoring the necessity for further high-quality, randomized research to conclusively establish the clinical benefits and safety profile of the combined product.

Common questions about Аекол (FAQ)

Q: Is Аекол used for other conditions besides the main ones listed?

A: Official indications state that Аекол is used in the complex therapy for several specific conditions. These include applications for rectal fissures, hemorrhoids, trophic ulcers, cervical erosions, endocervicitis, and colpitis.

Q: Is Аекол considered a type of vitamin supplement?

A: Regulatory documents classify Аекол as a polyvitamin agent and a combination medicine. This classification indicates it is a pharmaceutical preparation that is processed and standardized, distinguishing it from general dietary supplements.

Q: Why do some people mention using Аекол for scarring?

A: Official information describes the product's general purpose as facilitating the body's natural processes of tissue repair and regeneration of surface tissues. This function is the established mechanism that may relate to its supportive use in healing and recovery contexts.

Q: Can children or teenagers use Аекол?

A: Major international regulatory documentation for the product does not contain established, verified age-related eligibility rules for Аекол. Consequently, official guidance on use in pediatric or adolescent age groups is not available from these sources.

Q: Can Аекол be used by people with sensitive skin?

A: Official texts list mild adverse reactions that include skin and subcutaneous tissue disorders such as pruritus (itching) and urticaria (hives). Separately, hypersensitivity to the components is a documented contraindication for use.

Q: What are the contraindications (who cannot use it) for Аекол?

A: The official product documentation states that a contraindication for use is hypersensitivity or increased sensitivity to any of the preparation’s components. Separate regulatory safety statements also associate high-dose intake with specific risks for pregnant/breast-feeding women and individuals who smoke.

Q: Are there any known long-term effects of using Аекол?

A: The key safety pattern noted in regulatory documents relates to the accumulation of its fat-soluble components with prolonged high-dose use. This accumulation carries the risk of a serious adverse reaction known as Hypervitaminosis A.

Q: What should be done if too much Аекол is used?

A: Due to the established risk of toxicity from accumulation, specifically Hypervitaminosis A, if any signs of excessive use are suspected, contact a healthcare professional or emergency services for evaluation.

Q: Why is consistency of use often highlighted for Аекол?

A: The active components of the product support long-term biological processes like cellular differentiation and tissue regeneration. Official texts emphasize that the full course of treatment is determined individually, and the prescribed duration should not be exceeded.

Q: Has Аекол been reviewed or approved by major health organizations?

A: Formal prescribing information or an official eligibility profile for Аекол is not established or publicly accessible in the regulatory documentation of major international government health agencies, such as the FDA, EMA, or Health Canada.

Q: How does Аекол relate to retinoids or retinol?

A: One of the active ingredients in Аекол is Retinol (Vitamin A), and its precursor is Beta Carotene, which the body converts to Retinoic Acid. These components are related to the broader pharmacological class of compounds known as retinoids.

Q: Can Аекол be used alongside light therapy treatments?

A: Research has documented that one of the active components, Menadione (Vitamin K3), acts as a photosensitizer in combination with light, suggesting a potential for interaction. This type of use is typically monitored under professional guidance.

Q: What does 'photosensitivity' mean in relation to Аекол?

A: The component Menadione (Vitamin K3) has been documented in research to act as a photosensitizer. This means the skin may experience an increased reaction to light after being exposed to the product.

Q: Why is sun protection emphasized when using Аекол?

A: The emphasis on sun protection is related to the component Menadione (Vitamin K3). Research identifies this component as a photosensitizer that can increase skin sensitivity to light exposure.

Q: Is Аекол considered a dermatological drug or a general health product?

A: Аекол is formally classified as a polyvitamin agent and a combination medicine. It is used for both topical application (dermatological and wound care) and oral intake (systemic support).

Q: What information is available about Аекол and kidney function?

A: Official documentation from major international government health agencies has not established formal restrictions related to conditions such as severe renal impairment.

Q: Is there any research on the effect of Аекол on liver enzymes?

A: Regulatory documents note the risk of severe Liver Damage related to Hypervitaminosis A from prolonged high-dose use. This established safety risk means that liver function is a relevant consideration during prolonged use.

Q: Do regulatory bodies classify Аекол as high or low risk?

A: Regulatory safety statements focus on the potential for Dose- or Exposure-Related Accumulation of the fat-soluble vitamins. This accumulation is associated with the risk of the serious adverse reaction, Hypervitaminosis A.

Q: What are the typical ingredients listed besides the active ones?

A: The preparation is an oily liquid solution that requires an oil base, such as refined vegetable oil, as its vehicle. This oil base is essential for the chemical stability and effective absorption of the fat-soluble active components.

How to Store and Dispose of Аекол

To ensure the stability of the fat-soluble vitamins, Аекол must be stored under specific regulatory conditions. The product must be stored at or below 25 C and kept within its original, tightly closed package to protect it from light and moisture. The stability of the active components is directly compromised by exposure to high heat.

Storage Requirements

Disposal Instructions

Official disposal requires that unused or expired medicine be discarded in accordance with local regulations. It is prohibited to dispose of the product by flushing it down the toilet, pouring it into drains, or mixing it with regular household rubbish. Pharmaceutical waste must be handled to prevent environmental contamination.